Details for New Drug Application (NDA): 065169
✉ Email this page to a colleague
The generic ingredient in CEFTRIAXONE is ceftriaxone sodium. There are twenty-six drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ceftriaxone sodium profile page.
Summary for 065169
Tradename: | CEFTRIAXONE |
Applicant: | Sandoz |
Ingredient: | ceftriaxone sodium |
Patents: | 0 |
Suppliers and Packaging for NDA: 065169
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 065169 | ANDA | Hospira, Inc | 0409-7332 | 0409-7332-20 | 10 VIAL, SINGLE-USE in 1 CARTON (0409-7332-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE (0409-7332-21) |
CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 065169 | ANDA | Hospira, Inc | 0409-7332 | 0409-7332-01 | 10 VIAL, SINGLE-USE in 1 CARTON (0409-7332-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE (0409-7332-11) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | Strength | EQ 250MG BASE/VIAL | ||||
Approval Date: | May 9, 2005 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | Strength | EQ 500MG BASE/VIAL | ||||
Approval Date: | May 9, 2005 | TE: | AP | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | Strength | EQ 1GM BASE/VIAL | ||||
Approval Date: | May 9, 2005 | TE: | AP | RLD: | No |
Complete Access Available with Subscription